| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 22,500 | $496.30 | $11,166,721.88 | -16.6% | +6.8% | - | |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Quart Barry D64 | Director | Sell | 20,129 | $41.51 | $835,554.79 | -61.6% | +11.9% | - | |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 12,048 | $41.56 | $500,714.88 | -42.0% | +11.9% | - | |
| Dec 15, 2025 | UTHR United Therapeutics Corp | Edgemond James45 | CFO And Treasurer | Sell | 3,517 | $495.36 | $1,742,192.60 | -4.0% | +6.8% | - | |
| Dec 15, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 100,000 | $0.21 | $21,200.00 | -2.4% | - | - | |
| Dec 15, 2025 | BCRX Biocryst Pharmaceuticals Inc | Barnes Alane P70 | Chief Legal Officer | Sell | 21,210 | $7.65 | $162,256.50 | -6.3% | +22.5% | - | |
| Dec 12, 2025 | MRMD Marimed Inc. | Shaw Timothy | Chief Operating Officer | Buy | 45,455 | $0.11 | $4,868.23 | +0.5% | - | - | |
| Dec 12, 2025 | ANIP Ani Pharmaceuticals Inc | Cook Meredith50 | Sr. VP, General Counsel &Sec. | Sell | 400 | $82.32 | $32,928.00 | -0.5% | -9.8% | - | |
| Dec 12, 2025 | ELAN Elanco Animal Health Inc | Kurzius Lawrence Erik77 | Director | Buy | 10,000 | $21.30 | $213,000.00 | +8.2% | +6.5% | - | |
| Dec 12, 2025 | PLNH Planet 13 Holdings Inc. | Groesbeck Robert | Co-ceo | Sell | 1,000,000 | $0.21 | $208,000.00 | -3.3% | - | - | |
| Dec 12, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 200,000 | $0.17 | $34,970.00 | -2.3% | - | - | |
| Dec 12, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 4,163 | $25.82 | $107,508.28 | -2.8% | -28.1% | - | |
| Dec 12, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $487.33 | $3,898,661.73 | -54.9% | +7.9% | - | |
| Dec 11, 2025 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 11,000 | $484.67 | $5,331,315.56 | -4.3% | +11.5% | - | |
| Dec 11, 2025 | PAHC Phibro Animal Health Corp | Bendheim Jack49 | President And CEO | Sell | 5,752 | $40.93 | $235,404.68 | -6.6% | +22.8% | - | |
| Dec 11, 2025 | ELAN Elanco Animal Health Inc | Modi Rajeev A. | See Remarks | Buy | 4,500 | $21.33 | $95,985.00 | +3.8% | +10.2% | - | |
| Dec 11, 2025 | UTHR United Therapeutics Corp | Malcolm Jan | Director | Sell | 50 | $482.98 | $24,149.00 | -9.6% | +11.5% | - | |
| Dec 11, 2025 | ELAN Elanco Animal Health Inc | Simmons Jeffrey N52 | President, CEO And Director | Buy | 22,000 | $21.75 | $478,495.60 | +15.2% | +10.2% | - | |
| Dec 11, 2025 | GSK Gsk Plc | Gsk Plc | 10% Owner | Buy | 1,470,000 | $19.00 | $27,930,000.00 | +8.8% | +12.8% | - | |
| Dec 11, 2025 | ELAN Elanco Animal Health Inc | Vanhimbergen Robert M56 | EVP And CFO | Buy | 6,950 | $21.64 | $150,426.50 | +5.9% | +10.2% | - | |
| Dec 10, 2025 | PCRX Pacira Biosciences, Inc. | Cross Shawn58 | Chief Financial Officer | Sell | 25,000 | $25.07 | $626,751.44 | -18.2% | -10.9% | - | |
| Dec 10, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $479.17 | $3,833,374.18 | -50.8% | +10.6% | - | |
| Dec 9, 2025 | UTHR United Therapeutics Corp | Mesa Nilda47 | Director | Sell | 187 | $481.63 | $90,064.83 | -3.4% | +11.2% | - | |
| Dec 9, 2025 | BIOA Bioage Labs, Inc. | Rubin Paul D | Chief Medical Officer | Sell | 18,000 | $12.00 | $216,000.00 | -100% | +63.5% | - | |
| Dec 9, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Sabag Mark | See "remarks" | Sell | 216,892 | $28.73 | $6,230,754.39 | -51.6% | +10.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.